EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of metformin in a novel experimental model of peripheral artery disease

Smriti Murali Krishna, Joseph Moxon iD, Ann-Katrin Kraeuter, Jonathan Golledge

Clinical Science · 2025

DOI: 10.1042/cs20243343 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, 2025. Verfasst von Smriti Murali Krishna und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Vascular Biology Unit, Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry, James Cook University, Town…. Hauptthemen laut MEDLINE: Metformin, Peripheral Arterial Disease, Ischemia, Hypoglycemic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Queensland Government (State of Queensland), Townsville Hospital and Health Service (THHS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Limited drug therapies for peripheral artery disease (PAD)-related walking impairment exist. There has been recent in repurposing the diabetes medication metformin to treat PAD. Animal studies designed to develop new PAD drug therapies have mainly used a model of temporary hind limb ischemia (HLI). The aim of this study was to test whether metformin improved blood supply and ambulation in a novel mouse model with ongoing HLI. Stable HLI was created in apolipoprotein E deficient mice by a two-stage surgical procedure. Five days after HLI was induced, mice were randomly allocated to receive metformin (n=16; 300mg/kg/day) or vehicle control (n=15) by oral gavage for four weeks. The primary outcome was hind limb blood supply assessed by laser Doppler. Other outcomes included treadmill performance and molecular changes in the ischemic limb. Metformin improved hind limb blood supply (p<0.001), but not physical performance, associated with increased phosphorylation of 5' adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase (p<0.05), reduced expression of thioredoxin interacting protein (p<0.05) and increased expression of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (p<0.05) in the ischemic muscles and increased circulating nitric oxide levels (p<0.05). Metformin improved blood supply in a novel model of limb ischemia associated with molecular changes previously linked with promoting angiogenesis but these changes did not translate to improved physical performance. The findings suggest that laser Doppler hind limb blood supply may not be an ideal outcome measure to gauge the success of a drug in patients with PAD-related walking impairment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminPeripheral Arterial DiseaseIschemiaHypoglycemic AgentsAnimalsDisease Models, AnimalHindlimbMiceMaleNitric Oxide Synthase Type IIIMice, Inbred C57BLRegional Blood FlowMice, Knockout, ApoEAMP-Activated Protein KinasesMuscle, Skeletal

Stichwörter der Autor:innen

ischaemiametforminperipheral arterial diseasepreclinical models

Substanzen

MetforminNitric Oxide Synthase Type IIIHypoglycemic AgentsAMP-Activated Protein Kinases

Autor:innen und Institutionen

  • The Vascular Biology Unit, Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry, James Cook University, Townsville, Queensland 4811, Australia.
  • The Australian Institute of Tropical Health and Medicine, Townsville, Queensland, Australia.
  • School of Molecular Science, La Trobe University, Kingsbury Drive, Bundoora, Victoria, Australia.
  • Faculty of Health and Life Sciences, Psychology, Northumbria University, Newcastle upon Tyne, U.K.
  • Brain Performance and Nutrition Research Centre, Northumbria University, Newcastle upon Tyne, U.K.
  • NUTRAN, Northumbria University, Newcastle upon Tyne, U.K.

ORCID-Profile: Joseph Moxon

Förderung

  • Queensland Government (State of Queensland)
  • Townsville Hospital and Health Service (THHS)

Zitieren

APA

Krishna, S. M., Moxon, J., Kraeuter, A. K., & Golledge, J. (2025). Effect of metformin in a novel experimental model of peripheral artery disease. Clinical Science. https://doi.org/10.1042/cs20243343

Vancouver

Krishna SM, Moxon J, Kraeuter AK, Golledge J. Effect of metformin in a novel experimental model of peripheral artery disease. Clinical Science. 2025. doi:10.1042/cs20243343

BibTeX
@article{Krishna2025,
  author = {Krishna, Smriti Murali and Moxon, Joseph and Kraeuter, Ann-Katrin and Golledge, Jonathan},
  title = {Effect of metformin in a novel experimental model of peripheral artery disease},
  journal = {Clinical Science},
  year = {2025},
  doi = {10.1042/cs20243343}
}
Kostenlos starten →